RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보 SCOPUS

      Identification of Alternatively Spliced Forms of human OSCAR in Osteoclasts

      한글로보기

      https://www.riss.kr/link?id=A101607420

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Objectives: Osteoclasts are multinucleated giant cells which can resorb bone and differentiated from hematopoietic cells. We have previously reported murine osteoclast-associated receptor (OSCAR) may be an important bone-specific regulator of osteocla...

      Objectives: Osteoclasts are multinucleated giant cells which can resorb bone and differentiated from hematopoietic cells. We have previously reported murine osteoclast-associated receptor (OSCAR) may be an important bone-specific regulator of osteoclast differentiation. We have cloned soluble form of human OSCAR (hOSCAR) and examined the role of hOSCAR on osteoclast differentiation.
      Methods: Osteoclast differentiation was induced by treatment with macrophage colony-stimulating factor (M-CSF)and receptor activator of nuclear factor kappa B ligand (RANKL) and tartrate-resistant acid phosphatase (TRAP)staining and pit formation were performed. Expression was measured by flow cytometry analysis, Northern and Western blot analysis.
      Results: hOSCAR is expressed in osteoclast cells and involved in the differentiation of osteoclasts from peripheral blood mononuclear cells (PBMC). Two alternatively spliced forms (soluble hOSCAR [hOSCAR-S]) of hOSCAR were identified from osteoclasts complementary deoxyribonucleic acid (cDNA) library derived from PBMC. Putative transmembrane domain was not found in hOSCAR-S forms and it suggested that these forms might be secreted from osteoclast cells. These secreted forms of hOSCAR attenuated RANKL-induced osteoclast formation and bone resorption.
      Conclusions: Human osteoclasts express at least five different OSCAR messenger ribonucleic acid (mRNA) isoforms which could play different regulatory roles for differentiation. The secreted forms of hOSCAR might be a negative regulator of membrane-bounded forms of OSCAR.

      더보기

      국문 초록 (Abstract)

      연구목적: 파골세포는 다핵 세포로서 골흡수를 유발한다. 생쥐에서 OSCAR는 파골세포 분화에서 중요한 역할을 함이 밝혀졌다. 인간 OSCAR의 분비형이 클로닝되었고 이들의 파골세포 분화에서...

      연구목적: 파골세포는 다핵 세포로서 골흡수를 유발한다. 생쥐에서 OSCAR는 파골세포 분화에서 중요한 역할을 함이 밝혀졌다. 인간 OSCAR의 분비형이 클로닝되었고 이들의 파골세포 분화에서의 역할을 분석하고자 하였다.
      연구방법: 파골세포 분화는 M-CSF와 RANKL의 처리에 의해 유도하였으며 TRAP 염색법과 pit 형성도를 측정하였다. 발현 정도는 유세포분석, Northern, 및 Western 분석 방법을 사용하였다.
      결 과: 인간 OSCAR는 파골세포에서 발현하였으며 PBMC로부터 유도되는 파골세포 형성에 관여하였다. 선택적 이어맞추기에 의해 만들어진 두 종류의 인간 OSCAR가 확인되었다. 이들은 막관통영역이 없는 구조로서 파골세포로부터분비되는 형태로 존재하였다. 이러한 분비형의 인간 OSCAR는 파골세포 분화 및 골흡수를 저해하였다.
      결 론: 인간 OSCAR는 최소 5종류의 구조적아형을 갖고 있으며, 이들은 서로 다른 역할을 하고 있다. 특히 분비형인간 OSCAR는 파골세포 분화에서 음성 조절자로서 역할을 한다.

      더보기

      참고문헌 (Reference)

      1 Wong BR, "TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor" 186 : 2075-2080, 1997

      2 Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation" 93 : 165-176, 1998

      3 Marks SC, Jr., "Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse" 67 : 11-18, 1976

      4 Walsh MC, "Osteoimmunology: Interplay between the immune system and bone metabolism" ANNUAL REVIEWS 24 : 33-63, 2006

      5 Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL" 95 : 3597-3602, 1998

      6 Merck E, "OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells" 104 : 1386-1395, 2004

      7 Suda T, "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families" 20 : 345-357, 1999

      8 Merck E, "Ligation of the FcR gamma chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils" 176 : 3149-3156, 2006

      9 Ishida N, "Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator" 277 : 41147-41156, 2002

      10 Ishikawa S, "Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR)" 16 : 1019-1025, 2004

      1 Wong BR, "TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor" 186 : 2075-2080, 1997

      2 Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation" 93 : 165-176, 1998

      3 Marks SC, Jr., "Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse" 67 : 11-18, 1976

      4 Walsh MC, "Osteoimmunology: Interplay between the immune system and bone metabolism" ANNUAL REVIEWS 24 : 33-63, 2006

      5 Yasuda H, "Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesisinhibitory factor and is identical to TRANCE/RANKL" 95 : 3597-3602, 1998

      6 Merck E, "OSCAR is an FcRgamma-associated receptor that is expressed by myeloid cells and is involved in antigen presentation and activation of human dendritic cells" 104 : 1386-1395, 2004

      7 Suda T, "Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families" 20 : 345-357, 1999

      8 Merck E, "Ligation of the FcR gamma chain-associated human osteoclast-associated receptor enhances the proinflammatory responses of human monocytes and neutrophils" 176 : 3149-3156, 2006

      9 Ishida N, "Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator" 277 : 41147-41156, 2002

      10 Ishikawa S, "Involvement of FcRgamma in signal transduction of osteoclast-associated receptor (OSCAR)" 16 : 1019-1025, 2004

      11 Herman S, "Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis" 58 : 3041-3050, 2008

      12 Merck E, "Fc receptor gamma-chain activation via hOSCAR induces survival and maturation of dendritic cells and modulates Toll-like receptor responses" 105 : 3623-3632, 2005

      13 Sallusto F, "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha" 179 : 1109-1118, 1994

      14 Koga T, "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis" 428 : 758-763, 2004

      15 Kim N, "A novel member of the leukocyte receptor complex regulates osteoclast differentiation" 195 : 201-209, 2002

      16 Anderson DM, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function" 390 : 175-179, 1997

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-11-14 학술지명변경 외국어명 : Korean Journal of Bone Metabolism -> Journal of Bone Metabolism KCI등재후보
      2011-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.62 0.62 0.57
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.5 0.44 1.091 0.16
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼